Back to trial detailsIntake questionnaire
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Applying to Sarah Cannon Research Institute Oncology Partners · Nashville, Tennessee
Answer a few short questions to share with the research team.
0 of 3 answered